Vir Biotechnology, Inc.VIRNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank94
5Y CAGR+45.0%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
+45.0%/yr
Long-term compound
Percentile
P94
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 384.79% |
| Q3 2025 | -57.01% |
| Q2 2025 | 15.95% |
| Q1 2025 | -49.95% |
| Q4 2024 | 60.38% |
| Q3 2024 | -88.90% |
| Q2 2024 | -142.16% |
| Q1 2024 | 52.94% |
| Q4 2023 | 37.10% |
| Q3 2023 | 13.32% |
| Q2 2023 | -70.10% |
| Q1 2023 | 13.57% |
| Q4 2022 | -146.93% |
| Q3 2022 | 229.68% |
| Q2 2022 | -117.45% |
| Q1 2022 | 67.65% |
| Q4 2021 | 21821.32% |
| Q3 2021 | -103.22% |
| Q2 2021 | 14742.64% |
| Q1 2021 | 101.00% |
| Q4 2020 | 60.11% |
| Q3 2020 | -99.72% |
| Q2 2020 | 227.21% |
| Q1 2020 | 1.28% |
| Q4 2019 | -33.17% |
| Q3 2019 | -33.34% |
| Q2 2019 | -14.94% |
| Q1 2019 | -8.56% |
| Q4 2018 | 19.87% |
| Q3 2018 | -42.45% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |